19-126
Showing 1 - 25 of >10,000
Seroprevalence of SARS-Cov-2 Antibodies in Children
Recruiting
- COVID
- +2 more
- Covid-19 Antibody testing (IgG and IgM)
- Blood Storage
-
Belfast, United Kingdom
- +4 more
Jan 5, 2022
Pulmonary Fibrosis After COVID-19 Pneumonia and Mechanism Study
Not yet recruiting
- Pulmonary Fibrosis
- COVID-19
- observational study
-
Kunming, Yunnan, China
- +1 more
Feb 7, 2023
Immune Dysregulation in Patients With COVID-19
Recruiting
- COVID-19
- Immunosuppression
- mid covid-19 patients
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jan 6, 2023
Idiopathic Membranous Nephropathy Trial in Beijing
Recruiting
- Idiopathic Membranous Nephropathy
-
Beijing, Beijing, China
- +2 more
Jan 18, 2023
COVID-19 Trial in Nanjing (Intramuscularly administered Ad5-nCoV vaccine, Aerosolized Ad5-nCoV, DelNS1-2019-nCoV-RBD-OPT1)
Not yet recruiting
- COVID-19
- Intramuscularly administered Ad5-nCoV vaccine
- +3 more
-
Nanjing, Jiangsu, ChinaJiangsu Provincial Center for Disease Control and Prevention
May 10, 2023
COVID-19 Pneumonia Trial in Beijing (conventional western medicine treatment, Dexamethasone oral tablet, Traditional Chinese
Recruiting
- COVID-19 Pneumonia
- conventional western medicine treatment
- +2 more
-
Beijing, Beijing, ChinaChina-Japan Friendship Hospital
Apr 2, 2023
SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10
Recruiting
- SARS-CoV-2 Infection
- Placebo
- +4 more
-
Hangzhou, Zhejiang, ChinaShulan (Hangzhou) Hospital
Nov 7, 2023
COVID-19 Pneumonia Trial (Low-Dose Radiation Therapy)
Not yet recruiting
- COVID-19 Pneumonia
- Low-Dose Radiation Therapy
- (no location specified)
Jan 22, 2023
ADHD Trial in United States (Amphetamine Sulfate, Placebo)
Completed
- Attention Deficit Hyperactivity Disorder
- Amphetamine Sulfate
- Placebo
-
Encino, California
- +30 more
Oct 20, 2020
Robotic Exoskeleton, Post-acute Covid-19 Syndrome, Rehabilitation Outcome Trial in Valladolid (Training with a Robotic Hand
Completed
- Robotic Exoskeleton
- +3 more
- Training with a Robotic Hand Exoskeleton
-
Valladolid, SpainCentro Hospitalario Padre Benito Menni
Nov 16, 2023
Endoscopic Operation in COVID-19 Infection: Cohort Study.
Not yet recruiting
- COVID-19
- Surgery-Complications
- endoscopic surgery
-
Beijing, ChinaPeking University Cancer Hospital & Institute
Jan 16, 2023
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
Recruiting
- COVID-19 Infection
- Immunization; Infection
-
Guangzhou, Guangdong, ChinaThe Third Affiliated Hospital of Sun Yat-sen University
Mar 15, 2023
Global Cardiovascular Risk Consortium
Completed
- Cardiovascular Diseases
- +6 more
-
Hamburg, GermanyUniversity Medical Center Hamburg-Eppendorf
Jul 18, 2022
Covid-19 Vaccine on Allogeneic Hematopoietic Stem Cell
Recruiting
- Hematologic Diseases
- COVID-19 vaccine(donor)
- COVID-19 vaccine(patient)
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 8, 2022
COVID-19 Pneumonia Trial in Jinan (Bevacizumab)
Recruiting
- COVID-19 Pneumonia
- Bevacizumab
- +4 more
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jan 13, 2023
Study on Immune Status of Patients With COVID-19
Recruiting
- COVID-19
- +2 more
- hospitalized patient
-
Jinan, Shandong, ChinaQilu Hospital of Shandong University
Jan 10, 2023
Physical and Emotional Status Elderly Infected and Non-Infected
Completed
- COVID-19 Pandemic
- Observational Tests
-
Mersin, TurkeyTarsus University
Jun 14, 2023
Acupuncture, Depression Trial (cheek acupuncture)
Not yet recruiting
- Acupuncture
- Depression
- cheek acupuncture
- (no location specified)
Jun 19, 2023
Brain Function Changes Following COVID-19 Infection
Not yet recruiting
- COVID-19
- (no location specified)
Jul 24, 2023
COVID-19 Trial in Shijiazhuang (Umbilical cord mesenchymal stem cells implantation, Comparator)
Recruiting
- COVID-19
- Umbilical cord mesenchymal stem cells implantation
- Comparator
-
Shijiazhuang, Hebei, ChinaThe First Hospital of Hebei Medical University
Feb 22, 2023
COVID-19, Renal Insufficiency, Chronic Trial in Beijing (Nirmatrelvir/ritonavir)
Recruiting
- COVID-19
- Renal Insufficiency, Chronic
-
Beijing, Beijing, ChinaChinese PLA General Hospital
Jul 6, 2023